SCHEMBL418028

SCHEMBL418028

[CH2]C([CH2])([CH2])CCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.60
LMNA P02545 3/20 0.60
NFKB1 P19838 1/20 0.60
PMP22 Q01453 1/20 0.60
GPR84 Q9NQS5 8/20 0.50
FFAR1 O14842 2/20 0.50
FFAR4 Q5NUL3 2/20 0.50
ABCC4 O15439 1/20 0.48
MAPT P10636 1/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
ALDH1A1 P00352 3/20 0.48
PTPN1 P18031 3/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
MEN1 O00255 2/20 0.48
FABP4 P15090 2/20 0.48
ALOX15 P16050 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15058597 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22GPR84
SCHEMBL758780 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22GPR84
SCHEMBL15057590 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22GPR84
SCHEMBL15361928 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22GPR84
SCHEMBL18419647 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22GPR84
SCHEMBL2862133 0.98 TSHR (0.57) TSHRLMNANFKB1PMP22GPR84
SCHEMBL1459016 0.88 MAPT (0.58) LMNAFFAR1FFAR4ABCC4MAPT
SCHEMBL15058882 0.86 FFAR4 (0.59) TSHRLMNANFKB1PMP22FFAR1
SCHEMBL15058713 0.85 TSHR (0.60) TSHRLMNANFKB1PMP22GPR84
SCHEMBL8863567 0.85 TSHR (0.60) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2827829-B1 PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL HENKEL AG & CO KGAA (DE) 2017-02-08 EP disclosed
EP-2827829-A2 PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL Henkel AG & Co. KGaA (DE) 2015-01-28 EP disclosed
WO-2013092186-A2 PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL HENKEL AG & CO. KGAA (DE) 2013-06-27 WO disclosed
US-20120021044-A1 Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same SNU R&DB FOUNDATION (KR) 2012-01-26 US disclosed
EP-2197834-A2 A NOVEL CATIONIC LIPID, A PREPARATION METHOD OF THE SAME AND A DELIVERY SYSTEM COMPRISING THE SAME Korea University Industrial & Academic Collaboration Foundation (KR) 2010-06-23 EP disclosed
WO-2009028824-A2 A NOVEL CATIONIC LIPID, A PREPARATION METHOD OF THE SAME AND A DELIVERY SYSTEM COMPRISING THE SAME KOREA UNIVERSITY INDUSTRIAL & ACADEMIC COLLABORATION FOUNDATION (KR) 2009-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021044-A1 Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same ACSS2, CETP, PLTP TSHR 1582/4885LMNA 1233/4885NFKB1 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.